<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2020</volume><submitter>Li Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Tissue-resident macrophages can be educated to tumor-associated macrophages (TAMs) by the tumor microenvironment and many types of macrophages express erythropoietic receptor (EPOR); However, little is known about the expression of EPOR on TAMs and the identity of EPOR&lt;sup>+&lt;/sup> TAMs in osteosarcoma lung metastasis has thus far remained elusive.&lt;h4>Methods&lt;/h4>EPOR-eGFPcre mice were used to determine the expression of EPOR on lung tissue-resident macrophages. Flow cytometry, RT-PCR, and Western blot were examined to define the identity of EPOR&lt;sup>+&lt;/sup> TAMs in 106 osteosarcoma lung metastasis specimens. Moreover, the clinicopathologic factors and prognosis of patients with CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> macrophages were compared.&lt;h4>Results&lt;/h4>We found that a subpopulation of mouse lung tissue-resident macrophages express EPOR and EPO enhances the proliferation of EPOR&lt;sup>+&lt;/sup> macrophages in mouse lung. A subpopulation of CD163&lt;sup>+&lt;/sup> macrophages expresses EPOR in human osteosarcoma lung metastasis specimens. CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup>TAMs increase 2.5 times in human osteosarcoma lung metastasis tissues; CD206, CD163, and PD1, which are known to have a significant role in TAM function had high expression in CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs compared with CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>-&lt;/sup> TAMs. Furthermore, CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs had higher M2 marker and cytokine expression in osteosarcoma tissues compared with para-osteosarcoma tissues. EPO enhanced the expression of M2 cytokines in primary CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs. Importantly, the percentage of CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs had a positive linear association with malignant phenotypes as well as poor disease-free survival and overall survival time.&lt;h4>Conclusions&lt;/h4>We have characterized TAMs expressing EPOR and CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> macrophages as TAMs in osteosarcoma lung metastasis patients, which are highly associated with tumor aggressiveness.</pubmed_abstract><journal>Journal of immunology research</journal><pagination>9374240</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7450330</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification and Functional Analysis of EPOR&lt;sup>+&lt;/sup> Tumor-Associated Macrophages in Human Osteosarcoma Lung Metastasis.</pubmed_title><pmcid>PMC7450330</pmcid><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Wei R</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification and Functional Analysis of EPOR&lt;sup>+&lt;/sup> Tumor-Associated Macrophages in Human Osteosarcoma Lung Metastasis.</name><description>&lt;h4>Background&lt;/h4>Tissue-resident macrophages can be educated to tumor-associated macrophages (TAMs) by the tumor microenvironment and many types of macrophages express erythropoietic receptor (EPOR); However, little is known about the expression of EPOR on TAMs and the identity of EPOR&lt;sup>+&lt;/sup> TAMs in osteosarcoma lung metastasis has thus far remained elusive.&lt;h4>Methods&lt;/h4>EPOR-eGFPcre mice were used to determine the expression of EPOR on lung tissue-resident macrophages. Flow cytometry, RT-PCR, and Western blot were examined to define the identity of EPOR&lt;sup>+&lt;/sup> TAMs in 106 osteosarcoma lung metastasis specimens. Moreover, the clinicopathologic factors and prognosis of patients with CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> macrophages were compared.&lt;h4>Results&lt;/h4>We found that a subpopulation of mouse lung tissue-resident macrophages express EPOR and EPO enhances the proliferation of EPOR&lt;sup>+&lt;/sup> macrophages in mouse lung. A subpopulation of CD163&lt;sup>+&lt;/sup> macrophages expresses EPOR in human osteosarcoma lung metastasis specimens. CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup>TAMs increase 2.5 times in human osteosarcoma lung metastasis tissues; CD206, CD163, and PD1, which are known to have a significant role in TAM function had high expression in CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs compared with CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>-&lt;/sup> TAMs. Furthermore, CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs had higher M2 marker and cytokine expression in osteosarcoma tissues compared with para-osteosarcoma tissues. EPO enhanced the expression of M2 cytokines in primary CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs. Importantly, the percentage of CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> TAMs had a positive linear association with malignant phenotypes as well as poor disease-free survival and overall survival time.&lt;h4>Conclusions&lt;/h4>We have characterized TAMs expressing EPOR and CD163&lt;sup>+&lt;/sup>EPOR&lt;sup>+&lt;/sup> macrophages as TAMs in osteosarcoma lung metastasis patients, which are highly associated with tumor aggressiveness.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2024-02-14T23:49:08.987Z</modification><creation>2020-09-12T07:07:03Z</creation></dates><accession>S-EPMC7450330</accession><cross_references><pubmed>32908942</pubmed><doi>10.1155/2020/9374240</doi></cross_references></HashMap>